Summary
2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101120706 |
| Start date: | 01-10-2023 |
| End date: | 30-09-2027 |
| Total budget - Public funding: | 5 957 997,50 Euro - 5 957 949,00 Euro |
Cordis data
Original description
2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).Status
SIGNEDCall topic
HORIZON-CL4-2022-DIGITAL-EMERGING-02-19Update Date
12-03-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
EU-Programme-Call
Search
Organisations
-
| UNIVERZITA PALACKEHO V OLOMOUCI (Coördinator)
-
| ARISTOTELIO PANEPISTIMIO THESSALONIKIS
-
| ELLINIKI ETAIRIA NOSOY ALZHEIMER KAI SYGGENON DIATARACHON SOMATEIO
-
| EVNIA APS
-
| FUNDACIO PRIVADA INSTITUT CATALA DE NANOTECNOLOGIA
-
| GRAPHEAL
-
| ITA-SUOMEN YLIOPISTO (University of Eastern Finland (UEF))
-
| NOVAPTECH
-
| Q-PLAN INTERNATIONAL ADVISORS PC
-
| University College Dublin (UCD)
-
| ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT